NO20043986L - Velsmakende oral suspensjon og framgangsmate for fremstilling av suspensjonen. - Google Patents

Velsmakende oral suspensjon og framgangsmate for fremstilling av suspensjonen.

Info

Publication number
NO20043986L
NO20043986L NO20043986A NO20043986A NO20043986L NO 20043986 L NO20043986 L NO 20043986L NO 20043986 A NO20043986 A NO 20043986A NO 20043986 A NO20043986 A NO 20043986A NO 20043986 L NO20043986 L NO 20043986L
Authority
NO
Norway
Prior art keywords
suspension
preparing
tasty oral
tasty
oral suspension
Prior art date
Application number
NO20043986A
Other languages
English (en)
Norwegian (no)
Inventor
Gary J Wiley
Ismat Ullah
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20043986L publication Critical patent/NO20043986L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20043986A 2002-03-12 2004-09-23 Velsmakende oral suspensjon og framgangsmate for fremstilling av suspensjonen. NO20043986L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36370402P 2002-03-12 2002-03-12
PCT/US2003/006855 WO2003077842A2 (en) 2002-03-12 2003-03-06 Palatable oral suspension and method

Publications (1)

Publication Number Publication Date
NO20043986L true NO20043986L (no) 2004-09-23

Family

ID=28041802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043986A NO20043986L (no) 2002-03-12 2004-09-23 Velsmakende oral suspensjon og framgangsmate for fremstilling av suspensjonen.

Country Status (16)

Country Link
US (1) US7175856B2 (pl)
EP (1) EP1482789A4 (pl)
JP (1) JP4619658B2 (pl)
CN (1) CN100337630C (pl)
AR (1) AR038947A1 (pl)
AU (1) AU2003220058B2 (pl)
BR (1) BR0308343A (pl)
CA (1) CA2478411C (pl)
MX (1) MXPA04008720A (pl)
NO (1) NO20043986L (pl)
NZ (1) NZ534746A (pl)
PE (1) PE20030885A1 (pl)
PL (1) PL212421B1 (pl)
TW (1) TW200304832A (pl)
WO (1) WO2003077842A2 (pl)
ZA (1) ZA200406585B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4705108B2 (ja) * 2004-10-15 2011-06-22 ズートツッカー アクチェンゲゼルシャフト マンハイム／オクセンフルト 改良されたパンコーティング法
US8653145B2 (en) * 2005-09-22 2014-02-18 Eaton Scientific Systems, Ltd. Method for alleviating climacteric symptoms
CA2681545C (en) 2007-03-28 2013-10-01 Apotex Technologies Inc. Fluorinated derivatives of deferiprone
CA2721134C (en) * 2007-06-13 2017-02-07 Wayne State University Board Of Governors A baclofen solution for low-volume therapeutic delivery
WO2008157308A2 (en) * 2007-06-13 2008-12-24 Wayne State University Board Of Governors A zwitterion solution for low-volume therapeutic delivery
JP5009707B2 (ja) * 2007-07-10 2012-08-22 東和薬品株式会社 不快な味がマスキングされたキノロン系抗菌剤の経口投与用液剤
US7884227B2 (en) * 2007-10-26 2011-02-08 Navinta Llc Felbamate with improved bulk density
WO2009092002A1 (en) * 2008-01-17 2009-07-23 Duquesne University Of The Holy Spirit Antiretroviral drug formulations for treatment of children exposed to hiv/aids
PL2268282T3 (pl) * 2008-04-25 2015-04-30 Apotex Tech Inc Płynny preparat deferypronu o przyjemnym smaku
ES2351643B1 (es) * 2009-07-27 2011-09-15 Laboratorio Jaer,S.A. Utilización de xilitol o sus derivados para el enmascaramiento gustativo de quimioterápicos del grupo del ácido quinolon-o-naftiridoncarboxílico administrados en alimentos destinados a ganado porcino.
WO2010034853A1 (es) 2008-09-23 2010-04-01 Laboratorio Jaer, S.A. Utilización de exilitol o sus derivados para el enmascaramiento gustativo de quimioterapicos del grupo del ácido quinolon-o-naftiridoncarboxilico administrados en alimentos destinados a ganado porcino
ES2335334B1 (es) * 2008-09-23 2011-02-09 Laboratorio Jaer, S.A. Utilizacion del xilitol para el enmascaramiento gustativo de amargantes en alimentos para animales.
ME01911B (me) 2009-07-03 2014-12-20 Apotex Tech Inc Fluorisani derivati 3-hidroksipiridin-4-ona
BR112012003592B8 (pt) 2009-08-19 2021-05-25 Eisai R&D Man Co Ltd composição farmacêutica contendo derivado de quinolina
US20110236494A1 (en) * 2010-03-04 2011-09-29 Ranbaxy Laboratories Limited Ciprofloxacin oral suspension
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
CN102397546A (zh) * 2010-09-10 2012-04-04 广州自远生物科技有限公司 一种用于嗅觉或味觉敏感型动物的药物给药方法
CN102397552B (zh) * 2010-09-10 2016-06-08 广州自远生物科技有限公司 一种含喹诺酮类的药物复合制剂及其制备方法和应用
WO2012166899A2 (en) 2011-06-03 2012-12-06 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
CA2957005C (en) 2014-08-28 2021-10-12 Eisai R&D Management Co., Ltd. High-purity quinoline derivative and method for manufacturing same
SG11201706630UA (en) 2015-02-25 2017-09-28 Eisai R&D Man Co Ltd Method for suppressing bitterness of quinoline derivative
WO2016140717A1 (en) 2015-03-04 2016-09-09 Merck Sharp & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
BR112017027227B1 (pt) 2015-06-16 2023-12-12 Eisai R&D Management Co., Ltd Agente anti-câncer
JP6553726B2 (ja) 2015-08-20 2019-07-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍治療剤
US12303505B2 (en) 2017-02-08 2025-05-20 Eisai R&D Management Co., Ltd. Tumor-treating pharmaceutical composition
BR112019023064A2 (pt) 2017-05-16 2020-06-09 Eisai R&D Man Co Ltd tratamento de carcinoma hepatocelular
CN111201013A (zh) * 2017-10-13 2020-05-26 研究三角协会 硫酸羟基氯喹制剂及其制备和使用方法
CN110151704A (zh) * 2019-07-05 2019-08-23 华裕(无锡)制药有限公司 阿奇霉素干混悬剂的制备方法
WO2025043236A1 (en) * 2023-08-24 2025-02-27 Joseph Fuisz Edible oral films, compositions, method of manufacture and packaging systems

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8103843L (sv) 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
JPS61180771A (ja) * 1985-01-05 1986-08-13 バイエル・アクチエンゲゼルシヤフト 安定な抗バクテリア剤水溶液
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
NL193682C (nl) 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
DE3831514A1 (de) * 1988-09-16 1990-03-22 Bayer Ag Ph-neutrale waessrige loesungen von chinoloncarbonsaeuren
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
IT1246383B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
JP3184239B2 (ja) * 1991-04-25 2001-07-09 京都薬品工業株式会社 矯味経口用医薬組成物
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
JPH05309314A (ja) 1992-05-07 1993-11-22 Sumitomo Pharmaceut Co Ltd コーティング方法
ZA945944B (en) 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
ATE245638T1 (de) * 1994-08-12 2003-08-15 Toyama Chemical Co Ltd Neue chinolon- oder naphthyridoncarbonsäurederivate oder deren salze
JPH10511640A (ja) * 1994-10-14 1998-11-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ サベルゾール経口懸濁剤
US5738875A (en) * 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
DK0801559T3 (da) * 1995-02-08 2002-06-17 Yamanouchi Europ Bv Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum
US5972379A (en) 1995-02-14 1999-10-26 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering a quinolone
WO1997029102A1 (en) * 1996-02-09 1997-08-14 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
JP3424038B2 (ja) * 1996-06-17 2003-07-07 株式会社日本点眼薬研究所 合成抗菌剤水性組成物
PL196867B1 (pl) * 1999-05-27 2008-02-29 Pfizer Prod Inc Kompozycja zyprazydonu
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Also Published As

Publication number Publication date
NZ534746A (en) 2006-06-30
MXPA04008720A (es) 2004-12-06
US20030187019A1 (en) 2003-10-02
AR038947A1 (es) 2005-02-02
WO2003077842A3 (en) 2004-03-25
TW200304832A (en) 2003-10-16
CN1642415A (zh) 2005-07-20
US7175856B2 (en) 2007-02-13
PL212421B1 (pl) 2012-09-28
JP2006504620A (ja) 2006-02-09
WO2003077842A2 (en) 2003-09-25
CA2478411C (en) 2010-09-28
JP4619658B2 (ja) 2011-01-26
AU2003220058B2 (en) 2008-05-01
CN100337630C (zh) 2007-09-19
CA2478411A1 (en) 2003-09-25
BR0308343A (pt) 2006-06-06
PL373570A1 (pl) 2005-09-05
AU2003220058A1 (en) 2003-09-29
PE20030885A1 (es) 2003-10-23
ZA200406585B (en) 2005-11-30
EP1482789A2 (en) 2004-12-08
EP1482789A4 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
IL164703A0 (en) ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof
PL373570A1 (pl) Doustna zawiesina o przyjemnym smaku i sposób jejwytwarzania
DE60227390D1 (de) Dehnbarer vliesstoff und methode zu dessen herstellung
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
NO20055633D0 (no) Oralt snusprodukt og fremgangsmate for a fremstille snusproduktet
HRP20040930A2 (en) Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
AU2003301066A8 (en) Al2o3-la2o3-y2o3-mgo ceramics, and methods of making the same
EP1539692A4 (en) FURANO DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
ZA200510378B (en) Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
AU2003256904A8 (en) Plurality of bags and method of making the same
AU2003253340A1 (en) Ceramic endoprosthetic elements and method for the production thereof
DE60224880D1 (de) Mikrobolometer und verfahren zu dessen herstellung
NO20051875D0 (no) Kjoleror og fremgangsmate for bruk av dette
AU2003300324A8 (en) Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
PL369850A1 (pl) Podstawione indole, sposób ich wytwarzania i ich zastosowanie do zwalczania bólu
PL371317A1 (pl) Pochodne acylo-3-karboksyfenylo-mocznika, sposób ich wytwarzania i ich zastosowanie
DE60205717D1 (de) 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
NO20052188D0 (no) System og fremgangsmate for fremstilling av polysulfid
DE50206656D1 (de) Cremiges nahrungsmittel und verfahren zu seiner herstellung
IL174975A0 (en) 2-phenyl-benzofuran derivatives, method for the production thereof and their use
DE69904084D1 (de) Schnellkochenden reis und verfahren zu dessen herstellung
NO20062043L (no) Glasstilformingsror og glasstykke og fremgangsmate for innbefatning av samme.
IL157793A0 (en) Caloporoside derivatives, methods for the production thereof and their use
FI20022130L (fi) Menetelmä syötävien päällystettyjen ytimien valmistamiseksi ja menetelmällä valmistetut ytimet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application